Literature DB >> 7685745

In vivo cytokeratin-expression pattern of stratified squamous epithelium from human papillomavirus-type-16-immortalized ectocervical and foreskin keratinocytes.

Q Sun1, K Tsutsumi, M Yokoyama, M M Pater, A Pater.   

Abstract

The association between human papillomavirus (HPV) type 16 and cervical squamous-cell carcinoma has been well documented, and HPV 16 DNA has been shown to immortalize human genital keratinocytes in vitro. Using a panel of cytokeratin(CK)-specific antibodies, we examined the CK expression pattern, an important characteristic of epithelia, of the stratified squamous epithelium reconstructed in vivo from monolayer cultures of 2 human ectocervical and 3 human foreskin keratinocyte cell lines immortalized by HPV 16 DNA. Whereas the abnormal epithelium formed from these grafts presented certain aspects of mature terminal differentiation, such as morphology and expression of CK10/11, the expression patterns for CK19, and especially CK13, were more obviously abnormal. CK18 expression was not detectable in any of the epithelia formed from the 5 cell lines. In contrast, for an HPV-16-immortalized endocervical cell line and the CaSki cervical-carcinoma cell line there was expression of CK18. Our results indicate that HPV-16-induced immortalization of keratinocytes is associated with disruption of the normal CK expression pattern in stratified squamous epithelium and that expression of particular CKs can be differentially disrupted.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7685745     DOI: 10.1002/ijc.2910540422

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  8 in total

1.  Neisseria gonorrhoeae elicits membrane ruffling and cytoskeletal rearrangements upon infection of primary human endocervical and ectocervical cells.

Authors:  J L Edwards; J Q Shao; K A Ault; M A Apicella
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

Review 2.  The molecular mechanisms used by Neisseria gonorrhoeae to initiate infection differ between men and women.

Authors:  Jennifer L Edwards; Michael A Apicella
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

3.  Characterization of human papillomavirus type 16 activity in separate biopsies from a carcinoma of the cervix uteri.

Authors:  D Kube; J Janda; K D Johannsmeyer; S Bergmann; U Kiessling
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

4.  Human papillomavirus type 16 E1circumflexE4 contributes to multiple facets of the papillomavirus life cycle.

Authors:  Tomomi Nakahara; Woei Ling Peh; John Doorbar; Denis Lee; Paul F Lambert
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

5.  Induction of p16 during immortalization by HPV 16 and 18 and not during malignant transformation.

Authors:  Y Nakao; X Yang; M Yokoyama; A Ferenczy; S C Tang; M M Pater; A Pater
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

6.  Characterization of keratin and cell cycle protein expression in cell lines from squamous intraepithelial lesions progressing towards a malignant phenotype.

Authors:  S Hietanen; K Syrjänen; S Syrjänen
Journal:  Br J Cancer       Date:  1998-03       Impact factor: 7.640

7.  Increased expression of SYCP2 predicts poor prognosis in patients suffering from breast carcinoma.

Authors:  Hongyan Zheng; Xiaorong Guo; Nan Li; Luyao Qin; Xiaoqing Li; Ge Lou
Journal:  Front Genet       Date:  2022-09-07       Impact factor: 4.772

8.  Relationship between CK19 expression, deregulation of normal keratinocyte differentiation pattern and high risk-human papilloma virus infection in oral and oropharyngeal squamous cell carcinoma.

Authors:  Angela Santoro; Giuseppe Pannone; Rossella Ninivaggi; Massimo Petruzzi; Andrea Santarelli; Giuseppe Maria Russo; Silvia Lepore; Michele Pietrafesa; Ilaria Laurenzana; Rosalia Leonardi; Paolo Bucci; Maria Iole Natalicchio; Alberta Lucchese; Silvana Papagerakis; Pantaleo Bufo
Journal:  Infect Agent Cancer       Date:  2015-12-15       Impact factor: 2.965

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.